Hiroe Ohyama, D.D.S., D.M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Students, Dental | 13 | 2024 | 173 | 5.470 |
Why?
|
| Dentistry, Operative | 8 | 2024 | 40 | 5.290 |
Why?
|
| Education, Dental | 10 | 2024 | 221 | 3.580 |
Why?
|
| Self-Assessment | 6 | 2024 | 393 | 3.250 |
Why?
|
| Students | 4 | 2022 | 1730 | 1.240 |
Why?
|
| Education, Distance | 2 | 2023 | 258 | 1.240 |
Why?
|
| Educational Measurement | 9 | 2024 | 1248 | 0.970 |
Why?
|
| Anatomy | 1 | 2024 | 126 | 0.810 |
Why?
|
| Licensure, Dental | 1 | 2022 | 19 | 0.810 |
Why?
|
| Clinical Competence | 9 | 2024 | 4783 | 0.700 |
Why?
|
| Immediate Dental Implant Loading | 1 | 2019 | 66 | 0.600 |
Why?
|
| Faculty, Dental | 3 | 2021 | 59 | 0.520 |
Why?
|
| Dental Caries | 3 | 2022 | 420 | 0.410 |
Why?
|
| Students, Medical | 2 | 2022 | 1927 | 0.400 |
Why?
|
| Dental Implants | 1 | 2019 | 791 | 0.360 |
Why?
|
| Educational Technology | 2 | 2022 | 59 | 0.340 |
Why?
|
| Mouth Rehabilitation | 1 | 2007 | 10 | 0.290 |
Why?
|
| Periodontitis | 7 | 2009 | 560 | 0.280 |
Why?
|
| Aggressive Periodontitis | 6 | 2009 | 59 | 0.270 |
Why?
|
| Smiling | 1 | 2007 | 72 | 0.270 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2003 | 3775 | 0.260 |
Why?
|
| Pandemics | 3 | 2022 | 8624 | 0.240 |
Why?
|
| Esthetics, Dental | 1 | 2007 | 268 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 4048 | 0.240 |
Why?
|
| Mouth Neoplasms | 4 | 2003 | 593 | 0.230 |
Why?
|
| Porphyromonas gingivalis | 5 | 2001 | 162 | 0.220 |
Why?
|
| Tooth Demineralization | 1 | 2022 | 4 | 0.210 |
Why?
|
| Aptitude Tests | 1 | 2022 | 20 | 0.210 |
Why?
|
| Radiography, Bitewing | 2 | 2020 | 35 | 0.210 |
Why?
|
| HLA-DQ Antigens | 5 | 2009 | 211 | 0.200 |
Why?
|
| Micromanipulation | 1 | 2002 | 52 | 0.200 |
Why?
|
| Dissection | 2 | 2020 | 298 | 0.200 |
Why?
|
| CDC2-CDC28 Kinases | 4 | 2004 | 110 | 0.190 |
Why?
|
| Japan | 3 | 2021 | 1369 | 0.190 |
Why?
|
| Chitosan | 1 | 2022 | 131 | 0.190 |
Why?
|
| Licensure | 1 | 2022 | 128 | 0.180 |
Why?
|
| Bacterial Outer Membrane Proteins | 3 | 2001 | 407 | 0.170 |
Why?
|
| Neck Muscles | 1 | 2020 | 100 | 0.170 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2021 | 225 | 0.170 |
Why?
|
| Hypoglossal Nerve | 1 | 2020 | 100 | 0.170 |
Why?
|
| Humans | 50 | 2024 | 760621 | 0.160 |
Why?
|
| Problem-Based Learning | 1 | 2022 | 352 | 0.160 |
Why?
|
| Dental Restoration Failure | 1 | 2019 | 155 | 0.160 |
Why?
|
| Dental Amalgam | 1 | 2018 | 65 | 0.150 |
Why?
|
| Composite Resins | 1 | 2018 | 69 | 0.150 |
Why?
|
| Feedback | 1 | 2022 | 791 | 0.150 |
Why?
|
| Acrylic Resins | 1 | 2018 | 135 | 0.150 |
Why?
|
| Polyurethanes | 1 | 2018 | 108 | 0.150 |
Why?
|
| Curriculum | 2 | 2021 | 3718 | 0.150 |
Why?
|
| Dental Prosthesis Design | 1 | 2019 | 264 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2005 | 2802 | 0.140 |
Why?
|
| Dental Prosthesis, Implant-Supported | 1 | 2019 | 231 | 0.140 |
Why?
|
| Schools, Dental | 1 | 2018 | 123 | 0.140 |
Why?
|
| Electroporation | 1 | 1998 | 255 | 0.140 |
Why?
|
| Reading | 1 | 2020 | 529 | 0.140 |
Why?
|
| Eosinophils | 2 | 1998 | 944 | 0.140 |
Why?
|
| Gingiva | 2 | 2009 | 406 | 0.130 |
Why?
|
| Antigens, Bacterial | 2 | 1998 | 1155 | 0.130 |
Why?
|
| Genes, MHC Class II | 1 | 1996 | 451 | 0.130 |
Why?
|
| Achievement | 1 | 2017 | 289 | 0.130 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2019 | 528 | 0.120 |
Why?
|
| Transfection | 4 | 2005 | 5781 | 0.110 |
Why?
|
| RNA, Complementary | 2 | 2002 | 45 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2009 | 1446 | 0.100 |
Why?
|
| Chronic Periodontitis | 2 | 2009 | 101 | 0.090 |
Why?
|
| Gene Expression Profiling | 3 | 2003 | 9411 | 0.090 |
Why?
|
| RNA, Neoplasm | 3 | 2002 | 749 | 0.090 |
Why?
|
| HLA-DR Antigens | 5 | 2009 | 630 | 0.080 |
Why?
|
| Learning | 1 | 2018 | 1739 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2018 | 6360 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2009 | 426 | 0.080 |
Why?
|
| Transforming Growth Factor alpha | 2 | 1998 | 135 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2007 | 134 | 0.070 |
Why?
|
| Tooth Attrition | 1 | 2007 | 7 | 0.070 |
Why?
|
| Occlusal Adjustment | 1 | 2007 | 8 | 0.070 |
Why?
|
| Dental Restoration Wear | 1 | 2007 | 7 | 0.070 |
Why?
|
| Crown Lengthening | 1 | 2007 | 6 | 0.070 |
Why?
|
| Tooth Discoloration | 1 | 2007 | 15 | 0.070 |
Why?
|
| Tooth Fractures | 1 | 2007 | 28 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 4573 | 0.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2007 | 186 | 0.070 |
Why?
|
| Lasers | 2 | 2002 | 952 | 0.070 |
Why?
|
| Dental Restoration, Permanent | 1 | 2007 | 128 | 0.070 |
Why?
|
| Crowns | 1 | 2007 | 155 | 0.070 |
Why?
|
| Retreatment | 1 | 2007 | 600 | 0.060 |
Why?
|
| Amino Acid Sequence | 8 | 2004 | 13451 | 0.060 |
Why?
|
| Male | 15 | 2024 | 359744 | 0.060 |
Why?
|
| Boston | 1 | 2017 | 9280 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2009 | 4090 | 0.060 |
Why?
|
| DNA Polymerase I | 2 | 2000 | 43 | 0.060 |
Why?
|
| HLA Antigens | 2 | 1999 | 1368 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2001 | 656 | 0.050 |
Why?
|
| T-Lymphocytes | 3 | 2001 | 10181 | 0.050 |
Why?
|
| DNA Primase | 2 | 2000 | 109 | 0.050 |
Why?
|
| Dental Enamel | 1 | 2022 | 60 | 0.050 |
Why?
|
| Female | 15 | 2024 | 391270 | 0.050 |
Why?
|
| Molecular Sequence Data | 7 | 2004 | 17624 | 0.050 |
Why?
|
| Caseins | 1 | 2022 | 103 | 0.050 |
Why?
|
| Dentistry | 1 | 2022 | 117 | 0.050 |
Why?
|
| Odontogenic Tumors | 1 | 2002 | 45 | 0.050 |
Why?
|
| Gels | 1 | 2022 | 419 | 0.050 |
Why?
|
| Mandibular Neoplasms | 1 | 2002 | 130 | 0.050 |
Why?
|
| Epitope Mapping | 2 | 2001 | 297 | 0.050 |
Why?
|
| Dentists | 1 | 2022 | 176 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2001 | 81 | 0.050 |
Why?
|
| Dentin | 1 | 2020 | 74 | 0.050 |
Why?
|
| Mandibular Nerve | 1 | 2020 | 59 | 0.040 |
Why?
|
| Basilar Artery | 1 | 1981 | 205 | 0.040 |
Why?
|
| Tic Disorders | 1 | 1981 | 136 | 0.040 |
Why?
|
| Trigeminal Neuralgia | 1 | 1981 | 106 | 0.040 |
Why?
|
| Proteins | 3 | 2000 | 6029 | 0.040 |
Why?
|
| Vertebral Artery | 1 | 1981 | 185 | 0.040 |
Why?
|
| Cysteine | 1 | 2005 | 895 | 0.040 |
Why?
|
| Biotinylation | 1 | 2000 | 184 | 0.040 |
Why?
|
| Interleukin-6 | 4 | 2009 | 3215 | 0.040 |
Why?
|
| Nerve Compression Syndromes | 1 | 1981 | 160 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 719 | 0.040 |
Why?
|
| Lymphocyte Activation | 3 | 1999 | 5496 | 0.040 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 1999 | 5 | 0.040 |
Why?
|
| Endodeoxyribonucleases | 1 | 2000 | 164 | 0.040 |
Why?
|
| Apoptosis | 3 | 2000 | 9501 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 378 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2000 | 1304 | 0.040 |
Why?
|
| Leukemia, Eosinophilic, Acute | 1 | 1998 | 5 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 2640 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1996 | 763 | 0.040 |
Why?
|
| Interleukin-4 | 2 | 2001 | 1130 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2000 | 367 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2004 | 1055 | 0.040 |
Why?
|
| Peptide Library | 1 | 1999 | 347 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1612 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2001 | 1249 | 0.040 |
Why?
|
| Chemokine CCL5 | 2 | 2009 | 215 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39261 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2001 | 2105 | 0.040 |
Why?
|
| Periodontal Ligament | 1 | 1997 | 117 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1998 | 175 | 0.030 |
Why?
|
| Cattle | 1 | 2022 | 3847 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4433 | 0.030 |
Why?
|
| Cell Line | 5 | 2005 | 15620 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2009 | 3615 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 3 | 2001 | 183 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2002 | 4024 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2009 | 3539 | 0.030 |
Why?
|
| Chemokine CCL2 | 2 | 2009 | 605 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2005 | 2907 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2007 | 2511 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1247 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 1999 | 452 | 0.030 |
Why?
|
| Cytokines | 2 | 2009 | 7343 | 0.030 |
Why?
|
| Mouth Mucosa | 3 | 2003 | 426 | 0.030 |
Why?
|
| Acyclovir | 1 | 1995 | 268 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 14660 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2005 | 3735 | 0.030 |
Why?
|
| ras Proteins | 1 | 1999 | 1052 | 0.030 |
Why?
|
| Genotype | 4 | 2009 | 12960 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6131 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 1995 | 151 | 0.030 |
Why?
|
| United States | 1 | 2021 | 72461 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2000 | 1802 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 1998 | 1254 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2009 | 17790 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2601 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65017 | 0.030 |
Why?
|
| Protein Binding | 3 | 2004 | 9335 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1995 | 478 | 0.020 |
Why?
|
| Age of Onset | 1 | 1998 | 3301 | 0.020 |
Why?
|
| Portal System | 1 | 1990 | 49 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1999 | 2611 | 0.020 |
Why?
|
| Blotting, Western | 3 | 2005 | 5039 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3568 | 0.020 |
Why?
|
| DNA, Complementary | 3 | 2001 | 1991 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2000 | 12766 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 1959 | 0.020 |
Why?
|
| Cells, Cultured | 5 | 2009 | 18957 | 0.020 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1990 | 114 | 0.020 |
Why?
|
| Electrolytes | 1 | 1990 | 274 | 0.020 |
Why?
|
| Thymine | 1 | 2009 | 69 | 0.020 |
Why?
|
| Periodontal Attachment Loss | 1 | 2009 | 144 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 1995 | 753 | 0.020 |
Why?
|
| Periodontal Pocket | 1 | 2009 | 167 | 0.020 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2009 | 46 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 1999 | 5125 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1693 | 0.020 |
Why?
|
| Keratinocytes | 2 | 2005 | 792 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2009 | 106 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 3113 | 0.020 |
Why?
|
| Jejunum | 1 | 1990 | 471 | 0.020 |
Why?
|
| Cytosine | 1 | 2009 | 212 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2009 | 22053 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 7593 | 0.020 |
Why?
|
| Luteolin | 1 | 2007 | 13 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1999 | 3707 | 0.020 |
Why?
|
| Health Policy | 1 | 2020 | 2677 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2007 | 8313 | 0.020 |
Why?
|
| Lymphocyte Subsets | 2 | 2001 | 310 | 0.020 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 359 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4354 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 5785 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1999 | 4353 | 0.020 |
Why?
|
| Alveolar Bone Loss | 1 | 2009 | 390 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 401 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 698 | 0.020 |
Why?
|
| Mink | 1 | 2005 | 31 | 0.020 |
Why?
|
| Statistics as Topic | 2 | 2003 | 2362 | 0.020 |
Why?
|
| Adult | 11 | 2009 | 219994 | 0.020 |
Why?
|
| Diploidy | 1 | 2005 | 132 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2003 | 6068 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 2753 | 0.020 |
Why?
|
| Animals | 10 | 2022 | 167963 | 0.020 |
Why?
|
| DNA Primers | 2 | 2000 | 2819 | 0.020 |
Why?
|
| Genome | 2 | 2003 | 1739 | 0.010 |
Why?
|
| Cricetinae | 2 | 1998 | 2427 | 0.010 |
Why?
|
| Histidine | 1 | 2005 | 311 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 7233 | 0.010 |
Why?
|
| Statistics, Nonparametric | 2 | 2001 | 2852 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 891 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2000 | 9185 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 814 | 0.010 |
Why?
|
| Immunoglobulin G | 3 | 2001 | 4541 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 458 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 565 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 1744 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15687 | 0.010 |
Why?
|
| Mutation | 2 | 2005 | 29932 | 0.010 |
Why?
|
| Alanine | 1 | 2005 | 606 | 0.010 |
Why?
|
| Antibodies, Bacterial | 2 | 2001 | 1468 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2001 | 3804 | 0.010 |
Why?
|
| DNA Replication | 2 | 2000 | 1412 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2001 | 68 | 0.010 |
Why?
|
| Treponema | 1 | 2001 | 38 | 0.010 |
Why?
|
| Cell Division | 2 | 2000 | 4463 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2009 | 10446 | 0.010 |
Why?
|
| Collagenases | 1 | 2001 | 221 | 0.010 |
Why?
|
| Antibodies | 1 | 2009 | 2421 | 0.010 |
Why?
|
| Cell Cycle | 2 | 2000 | 2934 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2001 | 326 | 0.010 |
Why?
|
| Cathepsins | 1 | 2001 | 242 | 0.010 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 4625 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1516 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 11903 | 0.010 |
Why?
|
| Immunodominant Epitopes | 1 | 2001 | 241 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 189 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2000 | 645 | 0.010 |
Why?
|
| Fusobacterium nucleatum | 1 | 2001 | 165 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2000 | 426 | 0.010 |
Why?
|
| Aged | 4 | 2007 | 169152 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1493 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1999 | 346 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4291 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1981 | 277 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1972 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2001 | 548 | 0.010 |
Why?
|
| Forelimb | 1 | 1999 | 115 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 76 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 1999 | 215 | 0.010 |
Why?
|
| Aging | 1 | 1997 | 8651 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1999 | 364 | 0.010 |
Why?
|
| Multigene Family | 1 | 2001 | 1077 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 193 | 0.010 |
Why?
|
| Lactones | 1 | 2000 | 319 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18416 | 0.010 |
Why?
|
| Amylases | 1 | 1998 | 169 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 317 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 268 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 279 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 413 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1999 | 576 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 425 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1999 | 881 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 2186 | 0.010 |
Why?
|
| Epithelium | 1 | 2001 | 1605 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1998 | 412 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1998 | 430 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 8515 | 0.010 |
Why?
|
| Base Sequence | 2 | 2000 | 12446 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 2262 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 775 | 0.010 |
Why?
|
| Glycine | 1 | 1999 | 662 | 0.010 |
Why?
|
| Mice | 5 | 2005 | 81208 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1997 | 321 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 3442 | 0.010 |
Why?
|
| Organelles | 1 | 1998 | 267 | 0.010 |
Why?
|
| Clone Cells | 1 | 1999 | 1660 | 0.010 |
Why?
|
| Sex Factors | 1 | 2009 | 10547 | 0.010 |
Why?
|
| Neutrophils | 2 | 2001 | 3767 | 0.010 |
Why?
|
| Campylobacter | 1 | 1995 | 57 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 1187 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2002 | 1738 | 0.010 |
Why?
|
| Middle Aged | 7 | 2009 | 220352 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1998 | 900 | 0.010 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1994 | 17 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1997 | 586 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1737 | 0.010 |
Why?
|
| Rheumatoid Factor | 1 | 1995 | 185 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 2558 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 2913 | 0.010 |
Why?
|
| Vero Cells | 1 | 1995 | 482 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 1889 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1900 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3800 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2698 | 0.010 |
Why?
|
| Neoplasms | 1 | 2002 | 22072 | 0.010 |
Why?
|
| Smoking | 1 | 2009 | 9073 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 3157 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4169 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 4122 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 663 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 1407 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1999 | 2192 | 0.010 |
Why?
|
| Risk Factors | 3 | 2009 | 74359 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 4219 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 6048 | 0.010 |
Why?
|
| Introns | 1 | 1994 | 978 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 40165 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1990 | 56 | 0.010 |
Why?
|
| Absorption | 1 | 1990 | 243 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1995 | 1871 | 0.010 |
Why?
|
| Family Health | 1 | 1995 | 1257 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1995 | 1529 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 15789 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4357 | 0.010 |
Why?
|
| Denervation | 1 | 1990 | 277 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3726 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2001 | 3663 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 10182 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1998 | 2860 | 0.000 |
Why?
|
| Regeneration | 1 | 1997 | 1506 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 16939 | 0.000 |
Why?
|
| Alleles | 1 | 1999 | 6898 | 0.000 |
Why?
|
| Chlorides | 1 | 1990 | 663 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 3465 | 0.000 |
Why?
|
| Cell Survival | 1 | 1998 | 5797 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11071 | 0.000 |
Why?
|
| Software | 1 | 2001 | 4419 | 0.000 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2001 | 4550 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12965 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1997 | 5870 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2001 | 58995 | 0.000 |
Why?
|
| Biological Transport | 1 | 1990 | 2086 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1995 | 6216 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2001 | 8035 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2234 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 3841 | 0.000 |
Why?
|
| Sodium | 1 | 1990 | 1594 | 0.000 |
Why?
|
| Adolescent | 3 | 2001 | 87810 | 0.000 |
Why?
|
| Models, Biological | 1 | 2001 | 9467 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 6498 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2007 | 23376 | 0.000 |
Why?
|
| Rats | 1 | 2000 | 23711 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1999 | 9287 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16546 | 0.000 |
Why?
|
| Lung | 1 | 2000 | 9994 | 0.000 |
Why?
|
| Child | 2 | 2001 | 79806 | 0.000 |
Why?
|
| Prognosis | 1 | 2001 | 29658 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2001 | 25942 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2001 | 41335 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 42063 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 29749 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 7509 | 0.000 |
Why?
|